Orexo AB (publ) ( ORXOF) - Stock Earnings
ORXOF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 22, 2026, midnight | — / — | — | — / — | — |
ORXOF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -39.8 million USD | 118.2 million USD |
| 2026Q1 | -133.9 million SEK | 5.0 million SEK |
| 2026Q2 | — USD | 3.5 million USD |
| 2026Q4 Est. | — | — |
ORXOF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -128.3 million USD | 638.8 million USD |
| 2024 | -203.0 million USD | 590.0 million USD |
| 2025 | 661.3 million USD | 525.1 million USD |
| 2026 Est. | — | — |
ORXOF
Price: $1.44
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -2.54
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 50.6 million